Scientific Advisory Committee
AnnaMaria Vezzani (Italy) Co-Chair
Annamaria Vezzani obtained her PhD degree in Neuropharmacology in Milano at the Mario Negri Institute for Pharmacology Research in 1982. She spent her post-doctoral period in Baltimore at the University of Maryland in 1983-1984 working on the mechanisms of epileptogenesis in experimental models of epilepsy. She spent additional post-doctoral periods at the University of Stockholm and at the Karolinska Institute between 1985 and 1999. She was on sabbatical at the Albert Einstein College of Medicine in 2002 in the laboratory of Developmental Epilepsy.
She is involved in studies on the biochemical and molecular mechanisms involved in the etiopathogenesis of seizures disorders using experimental models of epilepsy. The present research is focused on the functional role of neuroactive peptides and inflammatory mediators in the modulation of neuronal excitability and seizure-related neurodegeneration. Focus of the research is also on the mechanisms of pharmacoresistance.
Since 1997 she is Head of the Laboratory of Experimental Neurology in the Department of Neuroscience at the Mario Negri Institute for Pharmacological Research, Milan, Italy. She is member of the Editorial Board of Epilepsy Currents, Epilepsy Res and Neuroscience and Associate Editor for Experimental Models of Epilepsia. She is appointed of the Chair of the Commission on Neurobiology of International League Against Epilepsy which is promoting initiatives for improving translational research in epilepsy.
She is involved in studies on the biochemical and molecular mechanisms involved in the etiopathogenesis of seizures disorders using experimental models of epilepsy. The present research is focused on the functional role of neuroactive peptides and inflammatory mediators in the modulation of neuronal excitability and seizure-related neurodegeneration. Focus of the research is also on the mechanisms of pharmacoresistance.
Since 1997 she is Head of the Laboratory of Experimental Neurology in the Department of Neuroscience at the Mario Negri Institute for Pharmacological Research, Milan, Italy. She is member of the Editorial Board of Epilepsy Currents, Epilepsy Res and Neuroscience and Associate Editor for Experimental Models of Epilepsia. She is appointed of the Chair of the Commission on Neurobiology of International League Against Epilepsy which is promoting initiatives for improving translational research in epilepsy.
